Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Jan 17, 2024 4:22pm
59 Views
Post# 35832169

RE:RE:What is the market pricing?

RE:RE:What is the market pricing?

"If Gilles announces a return of lost revenue both should hopefully go up."

There are so many situations like that. We are in an information vaccum until we get the information.

WIll the merger happen?

What is the plan(more details at the end of the month)?
Has CZO's main client returned?
What are the terms of a diagnostic deal? 
What are the terms of a PGX deal?
Will the 5X and 10X PGX scale-up be a success this year? 5X scale-up about to be commissioned with Natex having 50% of the equipment and infrastructure believed required as of November 2023.
Will the avenanthramide pill pan out this year? Phase I completed by September.
WIll the fibrosis drug and others move to clinical trials.
etc. 


  

<< Previous
Bullboard Posts
Next >>